News

A diminishment of both hearing and vision is linked to an increased risk for dementia and mental decline, according to a new study.

Options for physicians are increasing in availability with fewer burdens for patients.

Minimizing clinic visits, maximizing use of imaging modalities are key.

Bausch + Lomb’s ClearVisc dispersive ophthalmic viscosurgical device has received FDA approval for use in ophthalmic surgery.

Physician offers patient counseling pearls for selected retinal diseases.

According to Verizon Business, BlueJeans Telehealth is way for providers and patients to conduct data-driven virtual care conversations.

During the trial, a patient gained vision, which lasted more than a year, after a single injection of an experimental RNA therapy into the eye.

The American Academy of Ophthalmology’s Truhlsen-Marmor Museum of the Eye is offering a free 2-part virtual series that will provide attendees an idea what is going on inside of their very own eyes and gut.

TCT can offer survival benefits for patients with a wide range of cancer diagnoses.

Drinking alcohol on a regular basis may decrease patients’ chances of developing cataracts that require surgery, new research shows.

Check out the latest cartoon!

Ophthalmologist offers pearls for management, treatment of myriad issues.

FLIO provides earlier diagnostic capabilities than other imaging modalities.

The results from Diabetic Retinopathy Clinical Research Network protocols have become the standard of care for treating DME and proliferative diabetic retinopathy.

Doug Mastel, who founded Mastel Precision Surgical Instruments Inc., passed away on March 20. He was 67.

Option demonstrates stable to improved visual acuity and retinal thickness.

Ophthalmologists refine procedures, offer better outcomes for patients.

Pearls for ophthalmologists guides for handling damage during open globe repair.

Rapid fluid identification may result in better visual outcomes.

A decision to stop the trial is based on results of a pre-planned interim sample size analysis conducted by an independent committee.

NCP should be considered for patients with discomfort, irritation, dryness, grittiness.

Physicians should consider basing decisions on findings from comprehensive consultation and examination.

Clinical-stage pharma company announces next step in investigation of BRIMOCHOL to treat presbyopia.

Product offers improvement in objective dry eye disease measures, providing relief.

ProQR Therapeutics has unveiled the results from its Phase 1/2 Stellar trial examining QR-421a n patients with Usher syndrome and non-syndromic retinitis pigmentosa.

A clinical trial of NCX 470 will evaluate the drug for the lowering of IOP in patients with open-angle glaucoma or ocular hypertension.

A word from Chief Medical Editor Peter J. McDonnell, MD.